September 14- 17, 2026
Raleigh, North Carolina.
Booth #530
What You'll See
Unified eClinical Platform
EDC, RTSM, CTMS, eConsent, ePRO, eSource, Protocol Automation, CSR Automation, and eTMF in a single integrated environment.
On-Demand Access to Study Data
Retrieve insights directly from study data using natural language, eliminating manual listings and turnaround delays.
Multi-Agent AI Data Review
One AI agent reads the protocol and CRFs, while another identifies discrepancies and generates queries; data managers review instead of building queries manually.
Book Your Demo Slot
Not attending SCDM?
Request a Virtual Demo
Recognized by the Society for Clinical Data Management for AI innovation in clinical data science two years in a row.
Clinion received the SCDM Innovation Award at the 2024 Annual Conference in Boston for AI innovations that move clinical data management from manual effort to intelligent automation.
Named a finalist for its production-ready Multi-Agentic AI for Clinical Data Review a system that works the way a data management team does, with the Data Manager in control.
Ask questions about your protocol, operational performance, and clinical data through a single conversational interface.
Accelerate the conversion of protocol requirements into structured CRFs while reducing repetitive study-build activities.
Generate datasets through natural-language prompts, review clinical data, and raise queries directly from the resulting records.
Specialized AI agents interpret study logic, identify contextual discrepancies, and prepare query drafts for Data Manager validation.
Surface important changes, repeated updates, and unusual patterns across extensive audit trail records.
Automate CRF field mapping and annotation against CDASH standards to support faster and more consistent study setup.
Create study reports, tables, summaries, and visualizations from current study data using natural-language instructions.
As Founder and CEO of Clinion, Manuj Vangipurapu brings a practical perspective on applying AI across the clinical trial lifecycle. In his oral presentation, he will explore how AI is reshaping the way modern clinical protocols are designed, drafted, and refined. He will also join a panel discussion on using predictive, AI-driven signal detection to strengthen centralized monitoring and RBQM.
Protocols are becoming increasingly patient-centric and technology-driven. Manuj examines the pivotal role AI now plays in how modern protocols are designed, drafted, and refined.
As trials grow more complex, decentralized, and data-rich, RBQM approaches built on static KRIs and periodic review are being rethought. Manuj joins the panel on what predictive, AI-driven monitoring looks like in practice.
Manuj Vangipurapu
CEO & Founder, Clinion
An AI expert driving advancements in clinical research and healthcare through purposeful, technology-led innovation. His vision is realized in Clinion an award-winning, AI-native platform redefining clinical trials with intelligent automation and next-generation technologies.
Connect on LinkedIn
Sudhakar Patil
AVP of Business Development
A business development leader helping sponsors and CROs modernize their clinical trials with Clinion's unified eClinical platform connecting teams with the right solutions across EDC, RTSM, CTMS, and AI-powered data management.
Connect on LinkedInVisit Clinion at Booth 530 to experience Agentic Assistant, explore our latest AI innovations, and see how one unified platform can support your clinical trials from study setup through reporting.
